Filana Therapeutics (FLNA) Other Working Capital Changes (2020 - 2026)

Filana Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$365000.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 4.7% year-over-year to -$365000.0 in Q2 2026; TTM through Jun 2026 was -$1.8 million, a 85.52% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 1028.01% from the prior year.
• Other Working Capital Changes was -$365000.0 for Q2 2026 at Filana Therapeutics, up from -$867000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $811000.0 in Q3 2020, with the low at -$509000.0 in Q4 2020.
• Average Other Working Capital Changes over 5 years is -$3823.5, with a median of -$91000.0 recorded in 2019.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 674.59% in 2022, then plunged 946.61% in 2024.
• Over 5 years, Other Working Capital Changes stood at $1.6 million in 2022, then sank by 58.59% to $663000.0 in 2023, then slumped by 946.61% to -$5.6 million in 2024, then surged by 83.04% to -$952000.0 in 2025, then surged by 61.66% to -$365000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$365000.0 (Q2 2026), -$867000.0 (Q1 2026), and -$952000.0 (Q4 2025), per Business Quant data.